Illumina Sequencing by Synthesis Workflow Overview

Added:

Long-Read Sequencing Technologies (Nanopore and SMRT)

While Illumina's Sequencing by Synthesis (SBS) is the dominant standard for high-throughput, low-error short-read sequencing, it has key limitations that long-read technologies address. Competitors like Pacific Biosciences (PacBio) SMRT sequencing and Oxford Nanopore Technologies (ONT) sequence single, long DNA molecules (kilobases to megabases) in real-time without PCR amplification. Illumina's short reads (50-300 bp) struggle to resolve highly repetitive genomic regions, large structural variations, and de novo assemblies. Long-read sequencing easily spans these complex regions, allowing for superior haplotype phasing and structural variant detection. Furthermore, nanopore sequencing enables direct detection of epigenetic modifications without the bisulfite conversion required in Illumina workflows, representing a paradigm shift in genomic analysis.

Basic DNA structure, including double-helix anatomy and complementary base pairing (A-T, C-G).
The enzymatic process of DNA replication, specifically how DNA polymerase synthesizes a complementary strand using a template.
The principles of Polymerase Chain Reaction (PCR), which is fundamental to understanding how DNA is amplified on the flow cell.
An introductory concept of Sanger sequencing to serve as a baseline comparison for Next-Generation Sequencing (NGS) technologies.
Bioinformatics data analysis pipelines, including quality control (Phred scores), alignment to a reference genome, and variant calling.
Specific high-throughput sequencing applications, such as RNA-Seq for transcriptomics, ChIP-Seq for epigenetics, and metagenomics.
Troubleshooting sequencing runs by analyzing cluster density, focus issues, and phasing/pre-phasing error metrics.
A comparative study of third-generation, long-read sequencing technologies (e.g., Pacific Biosciences SMRT sequencing and Oxford Nanopore) versus Illumina's short-read approach.
2.6M views16.1Klikes5:13@IlluminaIncOriginal Release: 2016-10-05

Illumina's Sequencing by Synthesis (SBS) technology enables high-throughput DNA sequencing through a four-step workflow: (1) Sample preparation adds adapters to DNA fragments and introduces sequencing motifs; (2) Cluster generation uses bridge amplification on a flow cell with complementary oligos to create millions of clonal DNA clusters; (3) Sequencing employs fluorescently labeled nucleotides that compete for incorporation, with each addition producing a detectable signal read by a camera; (4) Data analysis interprets these signals to determine the DNA sequence. The process achieves massively parallel sequencing where hundreds of millions of clusters are read simultaneously, with read length determined by the number of sequencing cycles performed.